Becton Dickinson prepares HUF 34 bln investment
U.S.-based medical tech manufacturer Becton Dickinson is expanding its syringe plant in Hungary’s Tatabánya through an investment of HUF 34 billion, for which the Hungarian government is providing a grant of HUF 2.7 bln, the Ministry of Foreign Affairs and Trade announced today.
The Hungarian investment, which will see the installation of new production lines at the plant, is expected to create 219 high added-value jobs, according to the announcement. The investment is currently at the planning phase and construction is set to start in 8-10 months. Once construction has begun, the project is expected to be completed in three years, the announcement added.
The company has invested USD 250 million in ramping up its production and creating jobs since 2007, Hungarian news agency MTI reported. At present the company has 700 employees in Tatabánya. According to public records, Becton Dickinson Hungary posted HUF 17.6 billion sales revenues in the financial year ending on September 30, 2015, MTI added. Net profit was HUF 2.19 bln during the period.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.